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Abstract. Clinicians could benefit from decision support systems in-
corporating the knowledge contained in clinical practice guidelines. How-
ever, the unstructured form of these guidelines makes them unsuitable for
formal representation. To address this challenge we translated a complete
set of pediatric guideline recommendations into Attempto Controlled En-
glish (ACE). One experienced pediatrician, one physician and a knowl-
edge engineer assessed that a suitably extended version of ACE can ac-
curately and naturally represent the clinical concepts and the proposed
actions of the guidelines. Currently, we are developing a systematic and
replicable approach to authoring guideline recommendations in ACE.
1 Introduction
Contemporary healthcare is characterized by widespread practice variation and
overuse, underuse, and misuse of medical resources [10–12]. To address these is-
sues, a worldwide initiative to create, disseminate, and implement clinical prac-
tice guidelines has arisen.
Clinical practice guidelines are defined as “systematically developed state-
ments to assist practitioner and patient decisions about appropriate healthcare
for specific clinical circumstances” [2]. Modern guidelines help to make explicit
the scientific basis for guideline statements. In their most common form, guide-
lines are documents that contain recommendations that support clinical decision-
making by healthcare professionals and patients.
More than 4000 guidelines on hundreds of clinical topics have been published
by a wide variety of organizations 3. These guidelines summarize the most current
understanding of what constitutes “best practice”.
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Guidelines are developed by teams of medical experts who systematically
review and appraise the relevant biomedical literature and apply rigorous meth-
ods to link recommendations about appropriate care to the supporting scientific
evidence. In general, the development process involves: (1) topic selection, (2)
convening a multidisciplinary panel, (3) defining scope and questions to be ad-
dressed, (4) searching the biomedical literature for relevant evidence and filtering
that evidence to ascertain the most representative and valid subset, (5) evalu-
ating evidence quality and creating evidence tables, (7) developing consensus
about appropriate care, (8) formulating recommendation statements and assign-
ing a recommending strength, (9) submitting the draft guideline for peer review,
and (10) publishing the final product.
However, guideline development is often handicapped by problems in 5 ar-
eas that detract from their use and usability: (1) defects in guideline quality,
(2) imprecise guideline language, (3) non-transparent knowledge synthesis, (4)
ineffective implementation and uptake, (5) problems formalizing guidelines. We
will explore each of these areas of deficiency and then describe an approach to
addressing these issues that applies controlled natural language tools.
1.1 Defects in Guideline Quality
A decade ago, Grilli [13] and Shaneyfelt [14] pointed out that guidelines were
not adhering to emerging quality standards. Criteria that define valid and useful
guidelines have been established and codified in the AGREE instrument [15] and
in the Conference on Guidelines Standardization (COGS) statement [16]. Grilli
reported that after examining 431 specialty society guidelines, 87% did not report
whether a literature search had been done, and 67% did not describe the type of
professionals involved in guideline development. Such defects in documentation
represent a threat to guideline quality. We propose a tool that incorporates
reminders to guideline authors about requisite content and prompts them to
document relevant information.
1.2 Imprecise Guideline Language
As early as 1995, Tierney et al. [17] noted that “as written, guidelines are often
difficult or impossible to implement”. They suggested that authors write recom-
mendations as rules in a simple “If-then-else” format with all the parameters
strictly defined. An updated view of this proposal suggests that authors should
be explicit about: when(i.e. under what circumstances); who; ought (i.e. at which
level of obligation); to do what; to whom; how; why.
Because guideline authors often do not address these questions, guideline
language is often vague and underspecified, and sometimes even frankly am-
biguous [18]. True ambiguity, i.e. statements that can be interpreted in two or
more discrete ways, is rarely intentional. However, vagueness and underspecifi-
cation are most often introduced when there is insufficient high-quality evidence
to support a recommendation. They are also used when the authors are unable
to reach consensus, when they have concerns about setting a legal standard of
care, and when economics dictate a course that reflects scarce resources. It would
be valuable to implementers if the authors were explicit about the reasons for
deliberate vagueness or underspecification.
Experience with the Guidelines Implementability Appraisal indicates that
each recommendation must be decidable (i.e., the guideline’s intended audience
should consistently determine whether each condition in the recommendation
has been satisfied), and each recommendation must be executable (i.e. the rec-
ommended action should be stated specifically and unambiguously), so that
members of the intended audience will execute the recommended action in a
consistent way [19]. Yet many current guidelines present statements of fact as
“recommendations”. For example, a recent guideline on breast cancer manage-
ment includes the following text as recommendation: “Adjuvant hormone ther-
apy for locally advanced breast cancer results in improved survival in the long
term.” The statement is not executable as written because it does not indicate
under what circumstances, who should do what to whom, how, and with what
level of obligation. Such statements of fact cannot be implemented without some-
one, in many cases the implementer rather than the guideline author, answering
these questions.
Additional implementation difficulties are brought about by use of the passive
voice, which obscures the actor. Likewise, in recommendations that are aimed
at clinicians, statements such as “Patients should receive ...” are unclear about
how such an event is to occur. Guidelines should recommend actions that are
within the purview of their intended audience.
Another common but troublesome construction is the use of the word “con-
sider” to decrease the level of intended obligation of a verb. It is rarely possible
to measure whether an action was “considered”. Since guideline recommenda-
tions are often intended to be part of quality improvement efforts, the lack of
measurability is problematic.
1.3 Deficiencies in Knowledge Synthesis
Guideline authors should explicitly define the quality of evidence that supports
recommendation statements and assign a level of recommendation strength. Evi-
dence quality is an indication of the authors’ confidence in their appraisal of what
benefits and harms can be anticipated if the recommendation is followed [20]. It
is based on an analysis of the validity, consistency, and relevance of the scientific
evidence supporting a recommendation statement. For example, multiple, well-
conducted randomized controlled trials on populations similar to a guideline’s
target population provide higher confidence than observational studies (cohort
and case-control studies). Likewise observational studies provide higher “qual-
ity” evidence than case-series and expert consensus. Recommendation strength
communicates the authors’ assessment of the importance of adhering to the rec-
ommendations. It is based on a value judgment about anticipated benefits, risks,
harms, and costs associated with adhering to a recommendation, as well as a
consideration of evidence quality. Recommendation strength is particularly im-
portant to guideline implementers who must design systems that support adher-
ence. Hussain found that less than 41% of randomly selected guideline statements
were accompanied by an indicator of recommendation strength [21].
1.4 Ineffective Implementation and Uptake
Balas calculated that only 14% of research findings filter down to everyday prac-
tice and that it takes an average of 17 years to do so [22]. This lag in the
incorporation of scientific advances into clinical care creates delays that deprive
patients of potential health benefits [23]. New evidence alone rarely leads to
improvements in practice [24, 25]. Effective mechanisms are needed to influence
clinicians to adopt practices based on evidence when such behavior change is
justified.
Practice guidelines constitute an important mechanism that can reduce the
delivery of inappropriate care and support the introduction of new knowledge
into clinical practice [26]. But the knowledge that they contain must be delivered
in an effective manner.
Grimshaw and Russell showed that the highest probability of influencing
clinician behavior occurs when patient-specific reminders are delivered at the
time and place of a consultation [27]. An electronic clinical decision support sys-
tem (CDSS) is a system that compares patient characteristics with a knowledge
base and then guides a health provider by offering patient-specific and situation-
specific advice.
1.5 Problems Formalizing Guidelines
There is a mismatch between the unstructured narrative form of published guide-
lines and the formality that is necessary for the operationalization of guideline
knowledge in clinical decision support systems. Uncritical translation of recom-
mendations into computable statements risks distortion of the guideline authors
intent. Patel and Ohno-Machado demonstrated that experience and background
of knowledge engineers impacts the accuracy of translation [28, 29].
2 Attempto Controlled English (ACE)
In the ERGO Project (Effective Representation of Guidelines with Ontologies) 4
we will demonstrate the feasibility of translating guideline knowledge into rules.
We propose to use Attempto Controlled English (ACE) [3] as an intermediate
representation between the implicit knowledge contained in the minds of the do-
main experts and the representation of that knowledge in an explicit computable
form.
ACE is a controlled natural language, i.e. a precisely defined subset of En-
glish with restrictions on vocabulary and grammar. These restrictions result
in increased terminological consistency, reduced ambiguity, consistent vocabu-
lary, potentially templated phrases, and a generally simplified sentence and text
4 http://gem.med.yale.edu/ergo/
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Fig. 1. This diagram shows the general architecture of our approach. It shows the
information and data flows between systems (in rectangular shapes) and users. The
current focus of the ERGO project lies on the guideline development part.
structure. ACE has the additional benefit of being supported by a parsing engine
that translates ACE texts into first-order logic, thus providing a computable for-
mat and supporting automatic reasoning. We plan to use ACE to encode the
summary recommendation statements that form the backbone of guideline doc-
uments. Often published in boldface, these key action statements embody the
critical knowledge about appropriate practice that is amplified by supporting
text.
Our primary goal is to develop an authoring tool that helps guideline au-
thors to reduce ambiguity, vagueness, incompleteness, and inconsistency, and
facilitates the translation of guideline recommendations into logic statements
that can be implemented in decision support systems. These systems generally
depend on production rules derived from guideline recommendations to create a
knowledge base. The decision support system compares an individual patient’s
characteristics (demographic descriptors and clinical findings) against these rules
to guide a health provider by offering patient-specific and situation-specific ad-
vice. A second goal is to demonstrate that ACE is a good candidate controlled
natural language for writing recommendations. Figure 1 shows the general ar-
chitecture of our approach.
3 Methods
A critical first step is to establish whether clinical guidelines can be adequately
expressed in ACE, and to identify potential barriers to the effective translation
of natural language guideline recommendations into controlled natural language.
To answer this question we decided to manually “ACE’ify” the set of recommen-
dations contained in the guideline “Diagnosis, Treatment, and Evaluation of the
Initial Urinary Tract Infection in Febrile Infants and Young Children” (UTI) [1].
UTI was chosen because (1) it includes a sufficient number of recommen-
dations to exercise the translation process, (2) its recommendations involve a
variety of action types and levels of obligation, (3) some recommendations in-
corporate a temporal sequence, (4) while others contain sentences related by
anaphoric references. In spite of its brevity, this guideline demonstrates many
challenges in translating recommendations.
The recommendations were translated by 3 members of the ACE team at the
University of Zurich (NEF, TK, KK). They individually created ACE statements
for each of the key action statements in the published guideline. Since the goal
was to determine feasibility, not reliability, we encouraged independent analysis
and translation.
Once translated into ACE, the recommendations were reviewed by a pedia-
trician with expertise in clinical guidelines (RNS), another physician (MK), and
by a knowledge engineer (GM). Judgments were made regarding the accuracy of
translation and the naturalness of the ACE statements. Obstacles encountered
in the translation process were captured and discussed after all translations were
completed.
4 Results
All eleven UTI key action statements were successfully translated into ACE (cf.
Appendix). The controlled natural language experts approached the transla-
tion problem somewhat differently, but each was able to create rules from each
natural language recommendation statement. The rules that they created are
interrelated, i.e. they have preconditions that must be fulfilled by other rules,
and consequences that can trigger other rules.
As might be expected, there was some level of variability in the ACE trans-
lations performed by the 3 ACE experts working independently. Some of the
textual variation is of course due to the fact that each rule can only be fully
understood in the context of the other rules.
For example, the guideline natural language statement: “Infants and young
children 2 months to 2 years of age, including those whose treatment initially
was administered parenterally, should complete a 7- to 14-day antimicrobial
course orally (Strength of Evidence-Strong).” was transformed into the following
statements.
NEF: Every young child must complete an oral antimicrobial-therapy for at
least 7 days and at most 14 days.
TK: If the patient is a young child who has a UTI then the doctor must
administer an oral antimicrobial-therapy that lasts at least 7 days and that lasts
at most 14 days.
Table 1. A comparison of three of the eleven original natural language guidelines
together with their ACE equivalents
Original guideline Attempto Controlled English
The presence of UTI should be considered
in infants and young children 2 months to 2
years of age with unexplained fever (strength
of evidence: strong).
If
the patient is a young child who has an unexplained fever
then
the clinician must consider UTI.
In infants and young children 2 months to 2
years of age with unexplained fever, the de-
gree of toxicity, dehydration, and ability to
retain oral intake must be carefully assessed
(strength of evidence: strong).
If
the patient is a young child who has an unexplained fever
then
the clinician must assess the degree of Toxicity and
must assess the degree of Dehydration and
must assess the Ability-to-retain-oral-intake.
If an infant or young child 2 months to 2
years of age with unexplained fever is assessed
as being sufficiently ill to warrant immedi-
ate antimicrobial therapy, a urine specimen
should be obtained by SPA or transurethral
bladder catheterization; [...] (strength of evi-
dence: good).
If
the patient is a young child who has an unexplained fever and
the patient is sufficiently-ill
then
the clinician should analyze a culture of a urine-specimen
that is obtained-by SPA or
that is obtained-by Transurethral-catheterization.
KK: Every febrile-young-child that has a UTI must undergo an antimicrobial-
therapy that is oral and that lasts at least 7 days and that lasts no more than
14 days.
Table 1 shows three of the original natural language guidelines together with
their ACE equivalents.
The pediatrician, the physician and the knowledge engineer concluded that
ACE is capable of accurately stating the clinical concepts and the actions de-
scribed in the guidelines recommendations. ACE statements were judged to
be acceptably “natural” sounding by the pediatrician (RNS), a native English
speaker.
We interpret the ACE guidelines as forward-chained rules that are executed
under the control of the clinician. Every rule consists of preconditions that must
be fulfilled to trigger the rule, and conclusions that are true after the rule fired,
and that can be used as preconditions for other rules. Execution under the control
of the clinician means that after each execution of a rule the clinician decides
whether he/she is satisfied with the conclusions found so far, or to execute further
rules.
In addition to the guidelines, the experts created a UTI background ontology
that included such statements as:
Every child is a person.
SPA is a method.
No analysis confirms X and excludes X.
Every antimicrobial-therapy is a therapy.
...
To get the rule machinery running, a number of initial facts are asserted that
originate from the patients electronic health record or that are manually asserted
by the clinician, for instance:
The patient is a young child.
The patient’s age is 1.5 years.
The patient has an unexplained fever.
...
The complete ACE version of the UTI guidelines is found in the appendix.
5 Obstacles to Translation
Several obstacles were encountered in the course of translation. The means by
which each was addressed is described below.
Medical Terminology The ACE vocabulary comprises predefined function
words (e.g., determiners, conjunctions, prepositions) and about 100,000 content
words (nouns, verbs, adjectives, adverbs). However, specialized medical termi-
nology is not part of the ACE lexicon. Several large standardized vocabularies of
medical terms exist, such as UMLS, SNOMED and LOINC. ACE has “hooks”by
which external vocabularies can be incorporated. In future work we plan to ex-
amine the feasibility of incorporating components of these vocabularies.
Though many of the medical terms can be found in the above mentioned
lexicons, the problem remains that terms, such as “ability to retain oral intake”,
“sufficiently ill” and “SPA”, require clear and consistent specifications by guide-
line authors. We plan to solve this problem by providing an authoring tool that
accepts only terms that are known to the system and that have a clearly defined
meaning.
It is possible to temporarily add content words to ACE by prefixing unknown
words with their respective word-class, for example, v:reevaluate, n:imaging-
studies, and a:ill-appearing. Using this approach, it was possible to translate
unrecognized medical terms into ACE constructs without using a specialized
lexicon.
Level of Obligation Considerable uncertainty accompanies most medical de-
cision making. Variation in evidence validity as well as the accuracy of clinical
observations and measurements contribute to this uncertainty.
Guideline recommendations imply a level of obligation. This level is conveyed
in two different ways. Specific statements that codify the quality of evidence
supporting the recommendation and/or the “strength” of the recommendation
accompany many guideline recommendations. In addition, guideline recommen-
dation statements often contain deontic terminology indicated by modal auxil-
liaries (e.g., “must”, “should”, “may”) or by use of other constructions (e.g., “is
appropriate”,“the Committee strongly recommends”).
At the outset of this study, only the modals “can” and “must” were avail-
able in ACE. Lomotan and colleagues demonstrated in [30] that these are not
sufficient to capture the range of obligations imposed by recommendations.
It has already been noted as a Best Practice 5 that a limited vocabulary of
“must/required/shall”, “should/recommended”, and “may/optional” (and their
negations) represent a limited vocabulary of keywords for use in Internet Re-
quests for Comments. In guideline recommendations “should” is the most fre-
quently used modal with a level of obligation between “can” and “must”. To
adequately represent the required levels, ACE was extended by the modals
“should/it is recommended that” and “may/it is admissible that”, and their
negated forms. This is already reflected in the examples of table 1.
6 Discussion and Future Work
In this work, we demonstrated that ACE can be used to express the recom-
mendation statements contained in clinical practice guidelines. These statements
express the semantics of the natural language in a format that is suitable for stan-
dardization. ACE guideline recommendation statements are natural sounding,
yet may be constrained in terms of grammar, vocabulary and style. Furthermore,
ACE statements can be translated to discourse representations structures in an
automated manner that can be further transformed into computer-interpretable
statements.
Now that we have demonstrated feasibility, our immediate plan is to build a
“look-ahead” editor for clinical practice guidelines expressed in ACE. This editor
is intended for use by guideline authors to remedy the defects in the development
process described in the introduction. The editor will incorporate 4 modules:
To improve the comprehensiveness of documentation of the elements neces-
sary to establish guideline validity and facilitate usability, we plan to include
a module that prompts authors to include each of the COGS checklist compo-
nents. In many cases, a guideline authoring group will be able to store standard
language that is repeated in each guideline, e.g., how conflicts of interest are
handled and the scheme for encoding evidence quality.
To facilitate knowledge synthesis, a module, perhaps configured as a wizard,
will lead the developers through a process of recording aggregate evidence quality
that supports each recommendation, the benefits, risks, harms, and costs antic-
ipated if the recommendation is carried out, and the judgment of the authors
regarding whether there is a preponderance of benefit or harm or an equilib-
rium between them. That information will be used to define a recommendation
strength for each statement. The recommendation strength will dictate and con-
strain choices for deontic terminology. Strong recommendations will permit use
of “must”, whereas lower level statements will limit the authors to the use of
“should” or “may”.
We plan to incorporate a WYSIWYM editor that dynamically displays the
knowledge defined so far and the specific options available for extending or revis-
5 http://www.faqs.org/rfcs/rfc2119.html
Fig. 2. This screenshot shows Kuhn’s ACE Editor adapted to the UTI terminology.
ing it. Such an editor module (similar to the existing ACE Editor 6) can be used
to address the imprecise language that is common in current guideline state-
ments. This approach was described by Scott et al. [6], and has been used by
Schwitter [7] and by Kuhn [5] working with controlled language grammars. The
editor will constrain authors to write in Attempto Controlled English and can
include specific constraints that address identified problems, e.g., flagging the
use of the term “consider”. Figure 2 shows a screen-shot of Kuhn’s ACE Editor,
adapted to the terminology of UTI. After the author has entered “If the patient
is a young child who has unexplained fever and the patient is not sufficiently-ill
then the doctor should analyze a urine-specimen that is”, the ACE Editor ex-
pects the author to enter the next word from the syntactically possible choices
offered by the scroll-menus. Alternatively, the author can freely enter text into
the “text” field.
Finally, to diminish the problem of delayed uptake and use of knowledge
contained in guidelines, we plan to take advantage of ACE’s ability to facilitate
translation into computable formats. We will transform the rules that are de-
fined into a standardized computer language (Arden Syntax [31]), and embed
these rules within a computer-mediated decision support system. That system
will combine the rules with clinical observations about specific patients that are
6 http://attempto.ifi.uzh.ch/aceeditor
derived from an electronic health record system to provide guidance about best
practices for care for that patient. As is the case with all decision support appli-
cations, the advice provided is advisory and is always presented as such to the
users.
7 Appendix: Complete ACE Version of UTI Guidelines
The appendix contains the complete ACE text of the UTI guidelines. The rules
derived from the UTI guidelines are designed to be executed under the control
of the responsible clinician. If the preconditions of a rule hold then the clinician
can decide to “fire” the rule. The consequences of this rule then either con-
firm/exclude a certain diagnosis or suggest — with various levels of obligation
— to perform additional tests. In both cases the clinician decides whether or not
to execute further rules.
The different levels of strength of evidence are represented in the following
way: “strength of evidence: strong” is represented by the modal verb “must”;
“strength of evidence: good” is represented by “should”; “strength of evidence:
fair” and “strength of evidence: opinion/consensus” are represented by “can”.
Note that the modals occur only in the consequences of the rules.
It is assumed that exactly two actors exist: the patient and the doctor. This
allows us to simplify the formalization. E.g. instead of “... perform Ultrasonog-
raphy on the patient”, we can just say “... perform Ultrasonography”, which
implicitly and unambiguously refers to the patient.
There is a small background ontology. Furthermore, there are some auxiliary
rules (2.2, 2.3, 2.4, 4.3, 4.4, 4.5, 4.6 and 8.2), which do not explicitly occur in the
original guidelines and look somewhat redundant. They are, however, needed to
interconnect the rules.
Lines prefixed by “#” are comments that are ignored by the ACE parser.
# Background Ontology
# ===================
Every child is a person.
Every infant is a person.
Every infant’s age is less than 1 year.
Every person whose age is more than 2 months and
whose age is less than 2 years is a young child.
SPA is a method.
Transurethral-catheterization is a method.
No analysis confirms X and excludes X.
Every antimicrobial-therapy is a therapy.
Ultrasonography is an imaging-study.
VCUG is an imaging-study.
RNC is an imaging-study.
# Background Rules
# ================
# Rule B.1
If
the doctor administers a therapy
then
the patient undergoes the therapy.
# Rule B.2
If
the patient undergoes a therapy
then
the therapy is completed or
the therapy is not completed.
# Rule B.3
If
the doctor performs an imaging-study
then
the imaging-study is completed or
the imaging-study is not completed.
# Recommendation 1
# ================
# Rule 1.1
If
the patient is a young child who has an unexplained fever
then
the doctor must consider UTI.
# Recommendation 2
# ================
# Rule 2.1
If
the patient is a young child who has an unexplained fever
then
the doctor must assess the degree of Toxicity and
must assess the degree of Dehydration and
must assess the Ability-to-retain-oral-intake.
# Rule 2.2
If
the doctor assesses the degree of Toxicity
then
the patient is toxic or
is not toxic.
# Rule 2.3
If
the doctor assesses the degree of Dehydration
then
the patient is dehydrated or
is not dehydrated.
# Rule 2.4
If
the doctor assesses the Ability-to-retain-oral-intake
then
the patient is able-to-retain-oral-intake or
is not able-to-retain-oral-intake.
# Recommendation 3
# ================
# Rule 3.1
If
the patient is a young child who has an unexplained fever and
the patient is sufficiently-ill
then
the doctor should analyze a culture of a urine-specimen
that is obtained-by SPA or
that is obtained-by Transurethral-catheterization.
# Recommendation 4
# ================
# Rule 4.1
If
the patient is a young child who has an unexplained fever and
the patient is not sufficiently-ill
then
the doctor should analyze a culture of a urine-specimen
that is obtained-by SPA or
that is obtained-by Transurethral-catheterization or
that is obtained-by a convenient method.
# Rule 4.2
If
the patient is a young child who has an unexplained fever and
the patient is not sufficiently-ill and
the doctor analyzes a culture of a urine-specimen
that is obtained-by a convenient method and
the analysis of the culture suggests UTI
then
the doctor should analyze a culture of a urine-specimen
that is obtained-by SPA or
that is obtained-by Transurethral-catheterization.
# Rule 4.3
If
the doctor analyzes a culture of a urine-specimen
that is obtained-by SPA or
that is obtained-by Transurethral-catheterization
then
the analysis of the culture confirms UTI or
excludes UTI.
# Rule 4.4
If
the doctor analyzes a culture of a urine-specimen that is obtained-by a convenient method
then
the analysis of the culture suggests UTI or
does not suggest UTI.
# Rule 4.5
If
the analysis of a culture of a urine-specimen confirms UTI
then
the patient has UTI.
# Rule 4.6
If
the analysis of a culture of a urine-specimen excludes UTI
then
the patient does not have UTI.
# Recommendation 5
# ================
#
# Recommendation 5 is integrated into the recommendations 3 and 4.
# Recommendation 6
# ================
# Rule 6.1
If
the patient is a young child who has an unexplained fever, and
the patient is toxic or
is dehydrated or
is not able-to-retain-oral-intake
then
the doctor can administer an antimicrobial-therapy and
can consider Hospitalization.
# Recommendation 7
# ================
# Rule 7.1
If
the patient is a young child and
the analysis of a culture of a urine-specimen confirms UTI
then
the doctor should administer a parenteral antimicrobial-therapy or
should administer an oral antimicrobial-therapy.
# Recommendation 8
# ================
# Rule 8.1
If
the patient is a young child who has UTI and
the patient undergoes an antimicrobial-therapy for 2 days and
does not show the expected response of the antimicrobial-therapy
then
the doctor should reevaluate the patient and
should analyze a culture of a second urine-specimen.
# Rule 8.2
If
the patient is a young child who has UTI and
the patient undergoes an antimicrobial-therapy for 2 days
then
the patient shows the expected response of the antimicrobial-therapy or
does not show the expected response of the antimicrobial-therapy.
# Recommendation 9
# ================
# Rule 9.1
If
the patient is a young child who has UTI
then
the doctor must administer an oral antimicrobial-therapy that lasts at least 7 days and
that lasts at most 14 days.
# Recommendation 10
# =================
# Rule 10.1
If
the patient is a young child who has UTI and
the antimicrobial-therapy of the patient is completed and
the imaging-study of the patient is not completed
then
the doctor should administer a therapeutically-dosed antimicrobial or
should administer a prophylactically-dosed antimicrobial.
# Recommendation 11
# =================
# Rule 11.1
If
the patient is a young child who has UTI and
the patient undergoes an antimicrobial-therapy for 2 days and
does not show the expected response of the antimicrobial-therapy
then
the doctor can perform Ultrasonography promptly, and
the doctor can perform VCUG or
can perform RNC.
# Rule 11.2
If
the patient is a young child who has UTI and
the patient undergoes an antimicrobial-therapy for 2 days and
shows the expected response of the antimicrobial-therapy
then
the doctor can perform Ultrasonography, and
the doctor can perform VCUG or
can perform RNC.
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